These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21818389)

  • 1. Therapeutic rescue of misfolded mutants: validation of primary high throughput screens for identification of pharmacoperone drugs.
    Janovick JA; Park BS; Conn PM
    PLoS One; 2011; 6(7):e22784. PubMed ID: 21818389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic rescue of misfolded/mistrafficked mutants: automation-friendly high-throughput assays for identification of pharmacoperone drugs of GPCRs.
    Smithson DC; Janovick JA; Conn PM
    Methods Enzymol; 2013; 521():3-16. PubMed ID: 23351731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput screen for pharmacoperones of the vasopressin type 2 receptor.
    Conn PM; Smith E; Hodder P; Janovick JA; Smithson DC
    J Biomol Screen; 2013 Sep; 18(8):930-7. PubMed ID: 23640875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo.
    Conn PM; Ulloa-Aguirre A; Ito J; Janovick JA
    Pharmacol Rev; 2007 Sep; 59(3):225-50. PubMed ID: 17878512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phenotypic high throughput screening assay for the identification of pharmacoperones for the gonadotropin releasing hormone receptor.
    Conn PM; Smith E; Spicer T; Chase P; Scampavia L; Janovick JA
    Assay Drug Dev Technol; 2014 May; 12(4):238-46. PubMed ID: 24831790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refolding of misfolded mutant GPCR: post-translational pharmacoperone action in vitro.
    Janovick JA; Brothers SP; Cornea A; Bush E; Goulet MT; Ashton WT; Sauer DR; Haviv F; Greer J; Conn PM
    Mol Cell Endocrinol; 2007 Jun; 272(1-2):77-85. PubMed ID: 17555869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptors.
    Conn PM; Ulloa-Aguirre A
    Adv Pharmacol; 2011; 62():109-41. PubMed ID: 21907908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoperone identification for therapeutic rescue of misfolded mutant proteins.
    Conn PM; Janovick JA
    Front Endocrinol (Lausanne); 2011 Mar; 2(6):. PubMed ID: 21633718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoperone rescue of vasopressin 2 receptor mutants reveals unexpected constitutive activity and coupling bias.
    Janovick JA; Spicer TP; Bannister TD; Scampavia L; Conn PM
    PLoS One; 2017; 12(8):e0181830. PubMed ID: 28767678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological chaperones correct misfolded GPCRs and rescue function: protein trafficking as a therapeutic target.
    Maya-Núñez G; Ulloa-Aguirre A; Janovick JA; Conn PM
    Subcell Biochem; 2012; 63():263-89. PubMed ID: 23161143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of testis function in hypogonadotropic hypogonadal mice harboring a misfolded GnRHR mutant by pharmacoperone drug therapy.
    Janovick JA; Stewart MD; Jacob D; Martin LD; Deng JM; Stewart CA; Wang Y; Cornea A; Chavali L; Lopez S; Mitalipov S; Kang E; Lee HS; Manna PR; Stocco DM; Behringer RR; Conn PM
    Proc Natl Acad Sci U S A; 2013 Dec; 110(52):21030-5. PubMed ID: 24324164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor antagonism/agonism can be uncoupled from pharmacoperone activity.
    Janovick JA; Spicer TP; Smith E; Bannister TD; Kenakin T; Scampavia L; Conn PM
    Mol Cell Endocrinol; 2016 Oct; 434():176-85. PubMed ID: 27389877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescue of misrouted GnRHR mutants reveals its constitutive activity.
    Janovick JA; Pogozheva ID; Mosberg HI; Cornea A; Conn PM
    Mol Endocrinol; 2012 Jul; 26(7):1179-88. PubMed ID: 22595961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Potential Pharmacoperones Capable of Rescuing the Functionality of Misfolded Vasopressin 2 Receptor Involved in Nephrogenic Diabetes Insipidus.
    Smith E; Janovick JA; Bannister TD; Shumate J; Scampavia L; Conn PM; Spicer TP
    J Biomol Screen; 2016 Sep; 21(8):824-31. PubMed ID: 27280550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoperones as a New Therapeutic Approach: In Vitro Identification and In vivo Validation of Bioactive Molecules.
    Ulloa-Aguirre A; Conn PM
    Curr Drug Targets; 2016; 17(13):1471-81. PubMed ID: 26953247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trafficking and quality control of the gonadotropin releasing hormone receptor in health and disease.
    Conn PM; Janovick JA
    Mol Cell Endocrinol; 2009 Feb; 299(2):137-45. PubMed ID: 19059461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of pharmacoperones to reveal GPCR structural changes associated with constitutive activation and trafficking.
    Janovick JA; Conn PM
    Methods Enzymol; 2010; 485():277-92. PubMed ID: 21050923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trafficking of G-protein-coupled receptors to the plasma membrane: insights for pharmacoperone drugs.
    Conn PM; Ulloa-Aguirre A
    Trends Endocrinol Metab; 2010 Mar; 21(3):190-7. PubMed ID: 20005736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transitioning pharmacoperones to therapeutic use: in vivo proof-of-principle and design of high throughput screens.
    Conn PM; Smithson DC; Hodder PS; Stewart MD; Behringer RR; Smith E; Ulloa-Aguirre A; Janovick JA
    Pharmacol Res; 2014 May; 83():38-51. PubMed ID: 24373832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoperones: targeting therapeutics toward diseases caused by protein misfolding.
    Ulloa-Aguirre A; Zariñán T; Conn PM
    Rev Invest Clin; 2015; 67(1):15-9. PubMed ID: 25857579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.